Mycosis fungoides and Sezary syndrome: Australian clinical practice statement
Details
Publication Year 2021-02,Volume 62,Issue #1,Page e8-e18
Journal Title
Australasian Journal of Dermatology
Publication Type
Review
Abstract
Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sezary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au).
Keywords
Biopsy; Hematologic Tests; Humans; Mycosis Fungoides/*diagnosis/mortality/*therapy; Neoplasm Staging; Prognosis; Sezary Syndrome/*diagnosis/mortality/*therapy; Skin/pathology; Skin Neoplasms/*diagnosis/mortality/*therapy; Survival Rate; Sezary syndrome; clinical practices statement; cutaneous T-cell lymphoma; management; mycosis fungoides
Department(s)
Surgical Oncology; Radiation Oncology; Pathology; Haematology
PubMed ID
33368169
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-06-06 07:51:50
Last Modified: 2025-06-06 07:57:04

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙